MSCs通过Nrf2通路调节氧化应激,用于治疗慢性阻塞性肺病
Yunchun Zhou1, Wenrui Zhou1, Yinghua Li1
1The People's Hospital of Yu Xi City (The Sixth Affiliated Hospital of Kunming Medical University), Yuxi, Yunnan, 653100, China.
BMC pulmonary medicine
|July 3, 2025
概括
介质干细胞 (MSC) 移植通过减少氧化应激和改善肺部状况,有效地治疗小鼠慢性阻塞性肺病 (COPD). 这项研究强调MSC作为COPD有前途的治疗方法,针对关键疾病途径.
科学领域:
- 再生医学是一种再生医学.
- 肺部医学 肺部医学
- 氧化压力研究研究 氧化压力研究
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个重大的公共卫生挑战.
- 目前的COPD治疗方法可以缓解症状,但不能治愈.
- 干细胞移植,特别是介质干细胞 (MSCs),是COPD的新兴治疗策略.
研究的目的:
- 在COPD小鼠模型中研究MSC移植的治疗潜力.
- 探索氧化应激和Nrf2通路在COPD病原和MSC治疗中的作用.
- 评估MSCs对COPD肺病变和纤维化的影响.
主要方法:
- 通过使用烟草烟雾和细菌脂多糖,建立了COPD的小鼠模型.
- 中介细胞干细胞 (MSCs) 被移植到COPD模型小鼠中.
- 肺病变,纤维化,氧化应激标志物 (例如4-HNE,ROS),炎症性细胞因子 (例如IL-6,CRP) 和血细胞计数被评估.
- 使用免疫光学分析了Nrf2通路的表达.
主要成果:
- 成功建立了一种COPD小鼠模型,其特征是肺炎,膜扩大和纤维化.
- 转移MSC显著降低了氧化应激标志物和炎症指标 (例如,降低了4-HNE,IL-6,ROS,CRP,EOS,WBC).
- MSC治疗导致肺部状况改善和肺纤维化减少,这表明通过Nrf2通路减轻了肺损伤.
结论:
- 移植的MSC在实验诱导的COPD上表现出治疗作用.
- 通过调节氧化应激和相关通路,包括Nrf2通路,MSCs可以改善COPD.
- 转移MSC是一种有前途的治疗方法来治疗COPD.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:46Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.3K
02:26NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K